The global transdermal drug delivery systems market is anticipated to grow at a CAGR of 6.5% during the forecast period (2023-2030). Increasing Demand for Pain Free Drug Delivery through skin with the help of patches is the major driver of the market growth. Especially in age of group of above 60 (older patients) are the biggest factor in the growth of the market globally. According to national library medicine, Diabetes in older adults is a significant and growing public health problem in the United States. About 40% of the adult diabetic population is age ?65 years. Approximately 20% of adult’s age ?65 years have a known diagnosis of diabetes, and a similar proportion (16%) is unaware that they have diabetes based on glycosylated hemoglobin (A1c), fasting plasma glucose, or oral glucose tolerance testing.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/transdermal-drug-delivery-systems-market
The emergence of technological innovations, such as the inclusion of microneedles or mechanical arrays in transdermal patches, is expected to provide the market with lucrative growth opportunities.
Another factor supporting the market growth includes the growing adoption of strategic initiatives by various market key players such as, the rising patient preference for pain-free drug administration has directed to a significant flow in the adoption rate of adhesive skin patches, which is anticipated to present the market with high growth possibility. For an instance, in May 2023, Kaneka has granted the exclusive patent rights in the Chinese mainland, Hong Kong, and Macao for two drugs in the form of skin patches to China’s Sunnovo Pharmaceutical Research. These two skin patch drugs are for the treatment of neurological diseases and mental illness. Different from oral medications, the active ingredients in the patches can be absorbed through the skin, reducing the chances of adverse gastrointestinal reactions and providing an alternative option for patients with dysphagia.
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape – includes Boehringer Ingelheim GmbH, Echo Therapeutics Inc., GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co. Inc., Mylan Pharmaceuticals, Inc., and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Transdermal Drug Delivery Systems Market Report Segment
By Type
- Patches
- Gel
By Application
- Hypertension
- Motion Sickness
- Pain Management
- Others (+Infection, Hormone, Respiratory and Metabolic)
A full report of Transdermal Drug Delivery Systems Market available @ https://www.omrglobal.com/industry-reports/transdermal-drug-delivery-systems-market
Global Transdermal Drug Delivery Systems Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- 4P Therapeutics, LLC
- Altaris
- Bayer AG
- Biogel Technology, Inc.
- Boehringer Ingelheim GmbH
- Echo Therapeutics, Inc.
- GlaxoSmithKline plc
- Hisamitsu Pharmaceutical Co. Inc.
- Mylan Pharmaceuticals, Inc.
- Novartis AG
- Noven Pharmaceuticals, Inc.
- Purdue Pharma L.P.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
